ADMA Biologics Inc (ADMA)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 426,454 382,809 330,245 283,177 258,216 234,293 208,108 181,890 154,079 130,481 110,072 93,998 80,944 68,517 58,112 48,069 42,220 40,301 37,248 36,021
Total assets US$ in thousands 488,678 390,618 376,399 350,875 329,182 348,997 343,027 340,788 348,461 300,558 296,932 308,032 276,253 238,640 232,814 235,667 207,673 189,976 191,542 210,524
Total asset turnover 0.87 0.98 0.88 0.81 0.78 0.67 0.61 0.53 0.44 0.43 0.37 0.31 0.29 0.29 0.25 0.20 0.20 0.21 0.19 0.17

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $426,454K ÷ $488,678K
= 0.87

The total asset turnover of ADMA Biologics Inc has been gradually increasing over time, indicating improvements in the company's efficiency in generating sales revenue relative to its total assets. The ratio has shown a consistent upward trend from 0.17 in March 2020 to 0.87 by December 2024. This suggests that the company has been able to make more effective use of its assets to generate revenue, which is a positive indicator of operational performance. The peak total asset turnover of 0.98 in September 2024 indicates that the company was able to generate almost $1 in sales for every dollar of assets during that period. Overall, the increasing trend in total asset turnover reflects improvements in the company's operational efficiency and effective management of its assets to drive revenue growth.